3α-Hydroxytibolone
Synthetic steroid
| 3α-Hydroxytibolone | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 5630-53-5 |
| PubChem | 100039 |
| DrugBank | |
| ChemSpider | 90324 |
| KEGG | |
3α-Hydroxytibolone is a synthetic steroid and a major active metabolite of tibolone, a drug used in hormone replacement therapy for menopause. It is one of the three primary metabolites of tibolone, the others being 3β-hydroxytibolone and Δ4-tibolone.
Pharmacology[edit | edit source]
3α-Hydroxytibolone exhibits estrogenic, progestogenic, and androgenic activities. It is primarily responsible for the estrogenic effects of tibolone, which include the alleviation of menopausal symptoms such as hot flashes and vaginal atrophy. The compound also contributes to the progestogenic and androgenic effects of tibolone, which help in maintaining bone density and libido.
Mechanism of Action[edit | edit source]
3α-Hydroxytibolone acts by binding to estrogen receptors, progesterone receptors, and androgen receptors. Its activity at these receptors helps in mimicking the effects of natural hormones in the body, thereby providing relief from menopausal symptoms and preventing osteoporosis.
Metabolism[edit | edit source]
Tibolone is metabolized in the body to form 3α-Hydroxytibolone, 3β-Hydroxytibolone, and Δ4-tibolone. The metabolism occurs primarily in the liver, and the metabolites are then distributed throughout the body to exert their effects.
Clinical Use[edit | edit source]
3α-Hydroxytibolone, as a metabolite of tibolone, is used in the treatment of menopausal symptoms and the prevention of osteoporosis in postmenopausal women. It is particularly beneficial for women who cannot take estrogen alone due to the risk of endometrial hyperplasia.
Side Effects[edit | edit source]
The side effects of 3α-Hydroxytibolone are similar to those of tibolone and may include breast tenderness, vaginal bleeding, and gastrointestinal disturbances. Long-term use may be associated with an increased risk of breast cancer and cardiovascular disease.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
